Publications found:
354
Sort by:
Global Zofenopril Calcium Market Growth 2026-2032
US$ 3,660.00
The global Zofenopril Calcium market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Zofenapril calcium, as a commonl...
January 2026
94 pages
Global Dabigatran Etexilate Drugs Market Growth 2026-2032
US$ 3,660.00
The global Dabigatran Etexilate Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Dabigatran etexilate is...
January 2026
145 pages
Global DTIs for Injection Market Growth 2026-2032
US$ 3,660.00
The global DTIs for Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Direct Thrombin Inhibitors (DTIs...
January 2026
145 pages
Global Factor Xa Inhibitors Market Growth 2026-2032
US$ 3,660.00
The global Factor Xa Inhibitors market size is predicted to grow from US$ 24030 million in 2025 to US$ 35890 million in 2032; it is expected to grow at a CAGR of 6.0% from 2026 to 2032. Factor Xa inhi...
January 2026
146 pages
Global Oral Factor Xa Inhibitors Market Growth 2026-2032
US$ 3,660.00
The global Oral Factor Xa Inhibitors market size is predicted to grow from US$ 23480 million in 2025 to US$ 35570 million in 2032; it is expected to grow at a CAGR of 6.2% from 2026 to 2032. Oral Fact...
January 2026
128 pages
Global Rivaroxaban Drugs Market Growth 2026-2032
US$ 3,660.00
The global Rivaroxaban Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Rivaroxaban is an oral anticoagul...
January 2026
134 pages
Global Vericiguat Tablets Market Growth 2026-2032
US$ 3,660.00
The global Vericiguat Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Vericiguat tablets are a medicat...
January 2026
79 pages
Telmisartan Market - 2024-2031
US$ 3,400.00
Telmisartan Marketis is growing with a CAGR of 4.30% during the forecast period 2026-2035. The Telmisartan Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned...
January 2026
37 pages
Polycythemia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Primary polycythemia, Secondary polycythemia, Pseudopolycythemia), By Treatment (Phlebotomy, Aspirin, Myelosuppressive Agents, Selective Serotonin Reuptake Inhibitor, Others), By Route of Administration (Oral, Intravenous, Intramuscular), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Polycythemia Market is projected to expand from USD 1.95 Billion in 2025 to USD 2.73 Billion by 2031, registering a compound annual growth rate of 5.77%. Polycythemia vera is a chronic myel...
January 2026
183 pages
Antithrombin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Usage (Therapeutics, Diagnostics, Research, Others), By Source (Human, Recombinant Goat Milk, Others), By Type (Anticoagulant, Antiplatelet, Thrombolytic Drugs), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Antithrombin Market is projected to expand from USD 793.11 Million in 2025 to USD 1082.43 Million by 2031, registering a CAGR of 5.32%. As a vital liver-produced glycoprotein, antithrombin...
January 2026
186 pages
Atherosclerosis Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Diagnosis (Ankle-brachial Index, Doppler Ultrasound, Echocardiogram, Electrocardiogram, Blood Tests, Others), By Treatment (Medication, Surgery, Others), By Route of Administration (Oral, Parenteral, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Atherosclerosis Drugs Market is projected to expand from USD 19.11 Billion in 2025 to USD 23.86 Billion by 2031, registering a CAGR of 3.77% throughout the forecast period. These pharmaceut...
January 2026
181 pages
Plasminogen Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Intravenous Injection, Eye Drops), By Application (Ligneous Conjunctivitis, Diabetic Foot, Wound Healing, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Plasminogen Market is projected to expand from USD 2.79 Billion in 2025 to USD 3.83 Billion by 2031, reflecting a CAGR of 5.42%. Plasminogen is a glycoprotein zymogen that converts to plasm...
January 2026
180 pages
Venous Thromboembolism Prophylaxis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Lower Extremity, Upper Extremity), By End Use (Hospitals & Clinics, Ambulatory care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Venous Thromboembolism Prophylaxis Market is projected to expand from USD 6.89 Billion in 2025 to USD 9.57 Billion by 2031, progressing at a CAGR of 5.63%. This therapeutic sector encompass...
January 2026
185 pages
Heart Failure Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (ACE Inhibitors, Angiotensin 2 Receptor Blockers, Beta Blockers, Diuretics, Aldosterone Antagonists, Inotropes, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Heart Failure Therapeutics Market is projected to expand from USD 8.47 Billion in 2025 to USD 12.28 Billion by 2031, reflecting a compound annual growth rate of 6.39%. This sector encompass...
January 2026
180 pages
Ischemic Heart Disease (IHD) Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Class (Angina Pectoris, Myocardial Infarction), By Drug Class (Anti-Dyslipidemic Drugs, Calcium Channel Blockers, Beta-Blockers, ACE Inhibitors, ARBs, Vasodilators, Antithrombotic Agents), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Ischemic Heart Disease (IHD) Drugs Market is projected to expand from a valuation of USD 6.23 Billion in 2025 to USD 7.98 Billion by 2031, progressing at a compound annual growth rate (CAGR...
January 2026
180 pages
Statin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Synthetic statin, Natural statin), By End-user (Hospitals & Clinics, Ambulatory Surgical Centers, others), By Region & Competition,, 2021-2031F
US$ 4,500.00
The Global Statin Market is projected to expand from USD 2.92 Billion in 2025 to USD 3.46 Billion by 2031, registering a Compound Annual Growth Rate (CAGR) of 2.87%. Statins are pharmaceutical agents...
January 2026
182 pages
Polycythemia Vera Drug Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Dasatinib, Idelalisib, Givinostat, M-009, Others), By End User (Hospitals& Clinics, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Polycythemia Vera Drug Market is projected to expand from USD 3.14 Billion in 2025 to USD 4.87 Billion by 2031, reflecting a compound annual growth rate of 7.59%. This market encompasses cy...
January 2026
182 pages
Clopidogrel Bisulphate Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Formulation (Tablets, Capsules, Others), By Application (Acute Coronary Syndrome, Myocardial Infarction, Stroke, Peripheral Artery Disease, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Clopidogrel Bisulphate Market is projected to expand from 7.98 Thousand Tonnes in 2025 to 11.59 Thousand Tonnes by 2031, reflecting a CAGR of 6.42%. Clopidogrel Bisulphate serves as a vital...
January 2026
185 pages
Direct Oral Anticoagulants (DOACs) Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Factor Xa Inhibitors, Direct Thrombin Inhibitors), By Indication (Atrial Fibrillation (AF), Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Stroke Prevention, Others), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Direct Oral Anticoagulants (DOACs) Market is projected to expand from USD 33.36 Billion in 2025 to USD 51.92 Billion by 2031, reflecting a CAGR of 7.65%. These pharmaceuticals serve as spec...
January 2026
185 pages
Eltrombopag Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Tablets, Oral Suspension), By Application (Chronic Immune Thrombocytopenia, Hepatitis C, Severe Aplastic Anemia, Others), By End User (Hospitals and Clinics, Pharmacies, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Eltrombopag Drugs Market is projected to expand from USD 2.68 Billion in 2025 to USD 4.22 Billion by 2031, registering a compound annual growth rate of 7.86%. Eltrombopag functions as an or...
January 2026
180 pages
Factor Xa Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Direct Factor Xa Inhibitors, Indirect Factor Xa Inhibitors), By Route of Administration (Oral, Injectable), By Application (Atrial Fibrillation, Deep Vein Thrombosis, Pulmonary Embolism, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Factor Xa Inhibitors Market is projected to expand from USD 23.46 Billion in 2025 to USD 33.13 Billion by 2031, reflecting a compound annual growth rate of 5.92%. Factor Xa, a critical seri...
January 2026
180 pages
Calcium Channel Blockers Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Drug Type (Dihydropyridine, Phenylalkylamine, Benzothizepine), By Application (Angina, Hypertension, Hypertrophic Cardiomyopathy, Arrhythmia, Others), By Distribution Channel (Online Pharmacies, Hospital Pharmacies, Retail Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Calcium Channel Blockers Market is projected to expand from USD 16.22 Billion in 2025 to USD 23.39 Billion by 2031, reflecting a compound annual growth rate of 6.29%. These pharmaceutical a...
January 2026
180 pages
Thalassemia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment (Iron Chelating Drugs, Blood Transfusions, Erythyroid Maturation Agents, Stem Cell Therapy, Others), By Type (Alpha Thalassemia, Beta Thalassemia), By End User (Hospitals, Research Institutes, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Thalassemia Treatment Market is projected to expand from USD 923.81 Million in 2025 to USD 1456.22 Million by 2031, registering a CAGR of 7.88%. Treatment modalities encompassed within this...
January 2026
180 pages
Orthostatic Hypotension Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Droxidopa, Fludrocortisone, Indomethacin, Midodrine Hydrochloride, NSAIDs, Pyridostigmine), By Diagnostics Test Type (Blood Tests, ECG, Echocardiogram, Stress Test), By End User (Ambulatory Surgical Centers, Diagnostic Centers, Hospitals & Clinics), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Orthostatic Hypotension Drugs Market is projected to expand from USD 622.19 Million in 2025 to USD 1026.93 Million by 2031, registering a CAGR of 8.71%. This market encompasses pharmaceutic...
January 2026
180 pages
Bleeding Disorders Treatment Market ? Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin Sealants, Others) By Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Others) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online) By End User (Clinics, Hospitals, Research Institutes, Others) By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Bleeding Disorders Treatment Market is projected to experience robust growth, increasing from a valuation of USD 17.81 Billion in 2025 to USD 29.82 Billion by 2031, reflecting a compound an...
January 2026
185 pages
Heparin-Induced Thrombocytopenia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Drug (Argatroban, Lepirudin, Danaparoid, Others), By Distribution Channel (Hospitals & Clinics, Ambulatory Care Centers, Others) By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Heparin-Induced Thrombocytopenia Market is projected to expand from USD 9.87 Billion in 2025 to USD 13.36 Billion by 2031, registering a compound annual growth rate of 5.18%. Heparin-Induce...
January 2026
185 pages
Heparin Market - Forecast from 2026 to 2031
US$ 3,950.00
The heparin market, with a 5.0% CAGR, is projected to increase from USD 6.598 billion in 2025 to USD 8.84 billion in 2031. The heparin market is a critical segment within the pharmaceutical industry,...
January 2026
153 pages
Intravenous Anticoagulants Market - 2024-2031
US$ 3,400.00
The Intravenous Anticoagulants Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliv...
January 2026
52 pages
Acute Cerebral Ischemic Stroke Drug Market - 2024-2031
US$ 3,400.00
Acute Cerebral Ischemic Stroke Drug Marketis is growing with a CAGR of 6.00% during the forecast period 2026-2035. The Acute Cerebral Ischemic Stroke Drug Market emerges as a key focus in DataM Intell...
January 2026
61 pages
Global Anticoagulants Market - 2025-2033
US$ 3,400.00
Global Anticoagulants Market reached US$ 35.46 billion in 2023 and is expected to reach US$ 72.67 billion by 2033, growing with a CAGR of 8.40% during the forecast period 2026-2033. The Global Anticoa...
January 2026
47 pages
The 2027-2032 World Outlook for Cardiovascular Drugs
US$ 1,195.00
This study covers the world outlook for cardiovascular drugs across more than ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for cardiovascular drugs. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
288 pages
Global Heparin Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... from 990 million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Heparin in global market, especially in North America, Europe ... and growth rate by type, application, from 2014 to 2019. Chapter 12, Heparin market forecast, by regions, type and application, with sales ...
January 2026
113 pages
